Serum Calretinin as a Biomarker in Malignant Mesothelioma
The early diagnosis of malignant mesothelioma (MM) could improve the prognosis of MM patients. To confirm an MM diagnosis, an immunohistochemical analysis of several tumor tissue markers, including calretinin, is currently required. Our aim is to evaluate serum calretinin as a potential biomarker in...
Saved in:
Main Authors: | Cita Zupanc, Alenka Franko, Danijela Štrbac, Metoda Dodič Fikfak, Viljem Kovač, Vita Dolžan, Katja Goričar |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/edcf4814866c47509e6a48e4eb336d3d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diagnostic and Prognostic Value of Three microRNAs in Environmental Asbestiform Fibers-Associated Malignant Mesothelioma
by: Veronica Filetti, et al.
Published: (2021) -
Modern management of malignant pleural mesothelioma
by: Patel SC, et al.
Published: (2016) -
Malignant Pleural Mesothelioma Nodal Status: Where Are We at?
by: Sara Ricciardi, et al.
Published: (2021) -
Extended Pleurectomy/Decortication for Malignant Pleural Mesothelioma: Humanitas’s Experience
by: Giuseppe Mangiameli, et al.
Published: (2021) -
Pain management in patients with malignant mesothelioma: challenges and solutions
by: Saunders J, et al.
Published: (2019)